TAKE2
LIVE

Serial Number

90798758

Owner

Take2 Health Limited

Attorney

Tama L. Drenski

Filing Date

Jun 28, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TAKE2 Trademark

Serial Number: 90798758 • Registration: 7172184

TAKE2 is a trademark filed by Take2 Health Limited on June 28, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Take2 Health Limited (2 trademarks)

21/F, Edinburgh Tower
Hong Kong , HK

Entity Type: 99

Trademark Details

Filing Date

June 28, 2021

Registration Date

September 26, 2023

Published for Opposition

May 23, 2023

Goods & Services

Medical services; medical diagnostic testing and reporting services; clinical diagnostic services, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals, all for medical purposes; genetic testing for medical purposes

DNA screening for scientific research purposes; providing diagnostic services for others in the fields of science, namely, providing reagent sample diagnostic services for scientific research purposes and scientific research related thereto; providing reagent sample testing services for others in the fields of science and scientific research related thereto; computer services in the field of pharmaceutical and health care computer products, namely, computer diagnostic services and computer graphics services; providing an on-line network environment featuring technology that enables users to store, analyze and share data in the fields of life science; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; consulting services in the field of genetic science and scientific research related thereto; providing temporary use of on-line non-downloadable software for the custom design and ordering of assays and reagents; design and development of computer software for use in analysis of biomolecules relating to diagnosing or screening cancer; design and development of computer software for use in analysis of biomolecules relating to studying genetics and DNA; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to diagnosing or screening cancer; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to studying genetics and DNA; design and development of computer software for use in Software as a Service (SaaS) services for use in genetic and bioinformatics analysis; product development of products used in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, and for use in chemical screening and diagnostic services; product research and development services for others in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology research; scientific research services in the nature of chemical screening analysis for scientific research purposes; product research and development services for others in the field of chemicals and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, and for use in chemical screening and diagnostic services for others; product research, development and design of pharmaceutical and health care products; laboratory analysis in the field of nucleic acids and proteins, among which the analysis of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality specification of same; medical and scientific research in the field of cancer detection and treatment

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 26, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 26, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 22, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 22, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Jul 18, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jul 18, 2023 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2023 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 13, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 28, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 28, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 28, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 21, 2022 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 21, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2021 NWOS
NEW APPLICATION ENTERED
Jul 1, 2021 NWAP